ORIGINAL RESEARCH article
Front. Pharmacol., 28 July 2016
Sec. Experimental Pharmacology and Drug Discovery
Volume 7 - 2016 | https://doi.org/10.3389/fphar.2016.00226
RETRACTED: Ophthalmic Combination of SurR9-C84A and Trichostatin-A Targeting Molecular Pathogenesis of Alkali Burn
- KR
Kislay Roy
- BS
Bhasker Sriramoju
- RK
Rupinder K. Kanwar
- JR
Jagat R. Kanwar *
Nanomedicine-Laboratory of Immunology and Molecular Biomedical Research, Centre for Molecular and Medical Research, School of Medicine, Faculty of Health, Deakin University Geelong, VIC, Australia
Summary
Citation
Roy K, Sriramoju B, Kanwar RK and Kanwar JR (2016) RETRACTED: Ophthalmic Combination of SurR9-C84A and Trichostatin-A Targeting Molecular Pathogenesis of Alkali Burn. Front. Pharmacol. 7:226. doi: 10.3389/fphar.2016.00226
Received
28 April 2016
Accepted
13 July 2016
Published
28 July 2016
Volume
7 - 2016
Edited by
Benedetto Falsini, Catholic University of the Sacred Heart, Italy
Reviewed by
Bashir M. Rezk, Southern University at New Orleans, USA; Rahul K. Keswani, University of Michigan, USA
Updates
This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.